S

ST Pharm Co Ltd
KOSDAQ:237690

Watchlist Manager
ST Pharm Co Ltd
KOSDAQ:237690
Watchlist
Price: 94 900 KRW 0.74% Market Closed
Market Cap: 1.9T KRW
Have any thoughts about
ST Pharm Co Ltd?
Write Note

ST Pharm Co Ltd
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

ST Pharm Co Ltd
Total Receivables Peer Comparison

Comparables:
207940
F
220100
L
141080
C
268600
E
456070

Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
S
ST Pharm Co Ltd
KOSDAQ:237690
Total Receivables
â‚©122.6B
CAGR 3-Years
47%
CAGR 5-Years
51%
CAGR 10-Years
N/A
Samsung Biologics Co Ltd
KRX:207940
Total Receivables
â‚©1T
CAGR 3-Years
40%
CAGR 5-Years
60%
CAGR 10-Years
N/A
F
FutureChem Co Ltd
KOSDAQ:220100
Total Receivables
â‚©3.6B
CAGR 3-Years
8%
CAGR 5-Years
5%
CAGR 10-Years
N/A
L
LegoChem Biosciences Inc
KOSDAQ:141080
Total Receivables
â‚©68.3B
CAGR 3-Years
48%
CAGR 5-Years
10%
CAGR 10-Years
76%
C
Cellivery Therapeutics Inc
KOSDAQ:268600
Total Receivables
â‚©1.8B
CAGR 3-Years
68%
CAGR 5-Years
35%
CAGR 10-Years
N/A
E
ENCell Co Ltd
KOSDAQ:456070
Total Receivables
â‚©2.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is ST Pharm Co Ltd's Total Receivables?
Total Receivables
122.6B KRW

Based on the financial report for Jun 30, 2024, ST Pharm Co Ltd's Total Receivables amounts to 122.6B KRW.

What is ST Pharm Co Ltd's Total Receivables growth rate?
Total Receivables CAGR 5Y
51%

Over the last year, the Total Receivables growth was 162%. The average annual Total Receivables growth rates for ST Pharm Co Ltd have been 47% over the past three years , 51% over the past five years .

Back to Top